Liquid Biopsy: Detection of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma

  • Alfred K. LamEmail author
  • Faysal Bin Hamid
  • Vinod GopalanEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 2129)


Circulating tumor cells (CTC) harvested in the blood of patients with esophageal squamous cell carcinoma (ESCC) are associated with certain clinical pathological parameters as well as patients’ prognosis and response to chemoradiation. They are the source of distant metastases and their mechanisms of pathogenesis is complex. In recent years, advance in technologies has allowed scientists to detect, enumerate, and isolate these cells for further analysis and monitor the diseases progression in patients with cancer. There are a few methods available for the identification of individual CTC and clusters of CTCs (circulating tumor microemboli). The most commonly used is detection by immunomagnetic method. Although all these methods have limitations, they are helpful for understanding the pathogenesis of CTCs with potential applications in clinical managements in patients with ESCC.

Key words

Esophagus Circulating tumor cell CTC CTM Squamous carcinoma 


  1. 1.
    Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Australas Med J 14:146–147Google Scholar
  2. 2.
    Lam KY, Ma LT, Wong J (1996) Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 49:124–129CrossRefGoogle Scholar
  3. 3.
    Lam KY, Law S, Wong J (2003) Low prevalence of incidentally discovered and early-stage esophageal cancers in a 30-year autopsy study. Dis Esophagus 16:1–3CrossRefGoogle Scholar
  4. 4.
    Alix-Panabieres C, Pantel K (2014) Challenges in circulating tumour cell research. Nat Rev Cancer 14:623–631CrossRefGoogle Scholar
  5. 5.
    Zhang WW, Rong Y, Liu Q, Luo CL, Zhang Y, Wang FB (2019) Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy. Clin Transl Oncol 21:828–835CrossRefGoogle Scholar
  6. 6.
    Lambert AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168:670–691CrossRefGoogle Scholar
  7. 7.
    Lu Y, Lian S, Cheng Y, Ye Y, Xie X, Fu C, Zhang C, Zhu Y, Iqbal Parker M, Jia L (2019) Circulation patterns and seed-soil compatibility factors cooperate to cause cancer organ-specific metastasis. Exp Cell Res 375:62–72CrossRefGoogle Scholar
  8. 8.
    Umer M, Vaidyanathan R, Nguyen NT, Shiddiky MJA (2018) Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies. Biotechnol Adv 36:1367–1389CrossRefGoogle Scholar
  9. 9.
    Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, Kumagai K, Irino T, Yoshikawa T, Matsuda S, Kitajima M, Kitagawa Y (2008) Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 15:3092–3100CrossRefGoogle Scholar
  10. 10.
    Bobek V, Matkowski R, Gürlich R, Grabowski K, Szelachowska J, Lischke R, Schützner J, Harustiak T, Pazdro A, Rzechonek A, Kolostova K (2014) Cultivation of circulating tumor cells in esophageal cancer. Folia Histochem Cytobiol 52:171–177CrossRefGoogle Scholar
  11. 11.
    Qiao YY, Lin KX, Zhang Z, Zhang DJ, Shi CH, Xiong M, Qu XH, Zhao XH (2015) Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: a case report. World J Gastroenterol 21:7921–7928CrossRefGoogle Scholar
  12. 12.
    Matsushita D, Uenosono Y, Arigami T, Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima H, Kijima Y, Kurahara H, Maemura K, Okumura H, Ishigami S, Natsugoe S (2015) Clinical significance of circulating tumor cells in peripheral blood of patients with esophageal squamous cell carcinoma. Ann Surg Oncol 22:3674–3680CrossRefGoogle Scholar
  13. 13.
    Reeh M, Effenberger KE, Koenig AM, Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu FG, Vashist YK, Izbicki JR, Pantel K, Bockhorn M (2015) Circulating tumor cells as a biomarker for preoperative prognostic staging in patients with esophageal cancer. Ann Surg 261:1124–1130CrossRefGoogle Scholar
  14. 14.
    Tanaka M, Takeuchi H, Osaki Y, Hiraiwa K, Nakamura R, Oyama T, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y (2015) Prognostic significance of circulating tumor cells in patients with advanced esophageal cancer. Esophagus 12:352–359CrossRefGoogle Scholar
  15. 15.
    Li H, Song P, Zou B, Liu M, Cui K, Zhou P, Li S, Zhang B (2015) Circulating tumor cell analyses in patients with esophageal squamous cell carcinoma using epithelial marker-dependent and -independent approaches. Medicine (Baltimore) 94:e1565CrossRefGoogle Scholar
  16. 16.
    Li SP, Guan QL, Zhao D, Pei GJ, Su HX, Du LN, He JX, Liu ZC (2016) Detection of circulating tumor cells by fluorescent immunohistochemistry in patients with esophageal squamous cell carcinoma: potential clinical applications. Med Sci Monit 22:1654–1662CrossRefGoogle Scholar
  17. 17.
    Su PJ, Wu MH, Wang HM, Lee CL, Huang WK, Wu CE, Chang HK, Chao YK, Tseng CK, Chiu TK, Lin NM, Ye SR, Lee JY, Hsieh CH (2016) Circulating tumour cells as an independent prognostic factor in patients with advanced oesophageal squamous cell carcinoma undergoing chemoradiotherapy. Sci Rep 6:31423CrossRefGoogle Scholar
  18. 18.
    Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D (2017) Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Onco Targets Ther 10:1363–1373CrossRefGoogle Scholar
  19. 19.
    Chen W, Li Y, Yuan D, Peng Y, Qin J (2018) Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy. Thorac Cancer 9:956–966CrossRefGoogle Scholar
  20. 20.
    Choi MK, Kim GH, I H, Park SJ, Lee MW, Lee BE, Park DY, Cho YK (2019) Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma. J Gastroenterol Hepatol 34:552–560CrossRefGoogle Scholar
  21. 21.
    Han D, Chen K, Che J, Hang J, Li H (2018) Detection of epithelial-mesenchymal transition status of circulating tumor cells in patients with esophageal squamous carcinoma. Biomed Res Int 2018:7610154PubMedPubMedCentralGoogle Scholar
  22. 22.
    Woestemeier A, Ghadban T, Riethdorf S, Harms-Effenberger K, Konczalla L, Uzunoglu FG, Izbicki JR, Pantel K, Bockhorn M, Reeh M (2018) Absence of HER2 expression of circulating tumor cells in patients with non-metastatic esophageal cancer. Anticancer Res 38:5665–5669CrossRefGoogle Scholar
  23. 23.
    Tellez-Gabriel M, Cochonneau D, Cadé M, Jubellin C, Heymann MF, Heymann D (2018) Circulating tumor cell-derived pre-clinical models for personalized medicine. Cancers (Basel) 11:E19CrossRefGoogle Scholar
  24. 24.
    Sharma S, Zhuang R, Long M, Pavlovic M, Kang Y, Ilyas A, Asghar W (2018) Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv 36:1063–1078CrossRefGoogle Scholar
  25. 25.
    Au SH, Edd J, Haber DA, Maheswaran S, Stott SL, Toner M (2017) Clusters of circulating tumor cells: a biophysical and technological perspective. Curr Opin Biomed Eng 3:13–19CrossRefGoogle Scholar
  26. 26.
    Huang Q, Wang Y, Chen X, Wang Y, Li Z, Du S, Wang L, Chen S (2018) Nanotechnology-based strategies for early cancer diagnosis using circulating tumor cells as a liquid biopsy. Nano 2:21–41Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Cancer Molecular Pathology, School of MedicineGriffith UniversityGold CoastAustralia

Personalised recommendations